President Trump capped insulin costs at $35 — then Harris-Biden took credit:

• President Trump capped Medicare enrollees’ out-of-pocket copays for insulin at $35/month — saving beneficiaries an average out-of-pocket savings of 66%.
  
  
• President Trump signed an executive order aimed at making insulin and EpiPens more affordable — but was blocked by the Harris-Biden administration almost as soon as they took office.
  
  
• Now, the Harris-Biden administration wants credit for something President Trump accomplished.

President Trump took additional action to lower the prices of prescription drugs — many of which were also blocked by Kamala Harris and Joe Biden as they take credit for others:

• President Trump issued an executive order that would have lowered prescription drug costs by eliminating kickbacks to middlemen, such as pharmacy benefit managers and health plan sponsors, ultimately lowering prescription drug costs for seniors by 30% and ensuring prices would not increase if Medicare premiums did.
  
  
  • The Harris-Biden administration blocked it from taking effect.
    
    
• President Trump issued an executive order to allow the safe, legal importation of prescription drugs from Canada and other countries where the price for identical drugs is lower — a policy Harris-Biden embraced.
  
  
• President Trump issued an executive order that would have ensured the United States pays the lowest price available among economically advanced countries for Medicare Part B and D drugs — the “Most Favored Nation” model.
  
  
  • The Harris-Biden administration blocked the model as they continue to complain other countries pay lower drug prices.